Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 5 | 2025 | 663 | 0.970 |
Why?
|
| Pneumonectomy | 5 | 2025 | 109 | 0.630 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 164 | 0.450 |
Why?
|
| Robotic Surgical Procedures | 2 | 2025 | 152 | 0.350 |
Why?
|
| Frailty | 2 | 2022 | 130 | 0.320 |
Why?
|
| Esophagectomy | 3 | 2024 | 48 | 0.300 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 20 | 0.260 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 26 | 0.260 |
Why?
|
| Retrospective Studies | 9 | 2025 | 6595 | 0.250 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2025 | 61 | 0.230 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 490 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2025 | 123 | 0.220 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 35 | 0.210 |
Why?
|
| Pain, Postoperative | 1 | 2025 | 162 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 447 | 0.210 |
Why?
|
| Esophageal Diseases | 1 | 2023 | 16 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 83 | 0.200 |
Why?
|
| Brazil | 1 | 2021 | 100 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 28 | 0.180 |
Why?
|
| Robotics | 1 | 2022 | 78 | 0.180 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 71 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2024 | 862 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 419 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 533 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 138 | 0.160 |
Why?
|
| Quality Improvement | 1 | 2024 | 441 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 934 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 141 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 315 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 497 | 0.140 |
Why?
|
| Male | 11 | 2025 | 29716 | 0.140 |
Why?
|
| Humans | 17 | 2025 | 63150 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 472 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 733 | 0.130 |
Why?
|
| Aged | 9 | 2025 | 14333 | 0.120 |
Why?
|
| Muscle, Smooth | 2 | 2013 | 134 | 0.110 |
Why?
|
| Female | 9 | 2025 | 32708 | 0.110 |
Why?
|
| Bronchodilator Agents | 2 | 2013 | 119 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2020 | 191 | 0.100 |
Why?
|
| Taste | 1 | 2013 | 36 | 0.100 |
Why?
|
| Bronchi | 1 | 2013 | 77 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 68 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2007 | 83 | 0.080 |
Why?
|
| Mediastinum | 2 | 2007 | 29 | 0.080 |
Why?
|
| Middle Aged | 6 | 2025 | 17478 | 0.080 |
Why?
|
| Calcium | 2 | 2013 | 573 | 0.080 |
Why?
|
| Ethanolamines | 1 | 2009 | 18 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 2066 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 5331 | 0.070 |
Why?
|
| Survival Rate | 2 | 2007 | 846 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2022 | 1293 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1372 | 0.070 |
Why?
|
| Etoposide | 1 | 2007 | 34 | 0.070 |
Why?
|
| Adult | 6 | 2025 | 16734 | 0.070 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 84 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2007 | 25 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 18 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 242 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2007 | 28 | 0.070 |
Why?
|
| Cisplatin | 1 | 2007 | 139 | 0.070 |
Why?
|
| United States | 3 | 2025 | 7827 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2006 | 73 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2006 | 152 | 0.060 |
Why?
|
| Cause of Death | 1 | 2006 | 221 | 0.060 |
Why?
|
| Stomach | 1 | 2024 | 86 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 143 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 113 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2022 | 122 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 28 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 952 | 0.050 |
Why?
|
| Emergencies | 1 | 2022 | 115 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2021 | 61 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 70 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 69 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1274 | 0.040 |
Why?
|
| Thoracotomy | 2 | 2013 | 46 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 639 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 337 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 238 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 1606 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 610 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 725 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 5625 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 61 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 487 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 892 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 969 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2009 | 14 | 0.020 |
Why?
|
| Oscillometry | 1 | 2009 | 13 | 0.020 |
Why?
|
| Histamine | 1 | 2009 | 21 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2009 | 20 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 44 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 504 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 60 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 202 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 158 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2007 | 8 | 0.020 |
Why?
|
| Donor Selection | 1 | 2006 | 17 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 33 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 180 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2007 | 87 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 170 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 116 | 0.020 |
Why?
|
| Reoperation | 1 | 2007 | 290 | 0.020 |
Why?
|
| Graft Survival | 1 | 2006 | 290 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3387 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 579 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2006 | 293 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 337 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 486 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 20610 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1559 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4673 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 1741 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2451 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10816 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 3754 | 0.010 |
Why?
|
| Child | 1 | 2006 | 4520 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 6229 | 0.010 |
Why?
|